Member access

4-Traders Homepage  >  Shares  >  Nyse  >  West Pharmaceutical Services Inc.    WST   US9553061055

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales1 2661 3681 4211 4121 530-
Operating income (EBITDA)219248273281334-
Operating profit (EBIT)142162183189229270
Pre-Tax Profit (EBT)109-----
Net income80,7112127132163-
EPS ( $)1,151,571,751,802,23-
Dividend per Share ( $)-0,39-0,470,51-
Yield-0,71%-0,85%0,93%-
Announcement Date02/21/2013
12:15pm
02/20/2014
12:00pm
02/19/2015
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt------
Finance------
Operating income (EBITDA)219248273281334-
Leverage
(Debt/EBITDA)
------
Capital Expenditure------
Book Value Per Share (BVPS)------
Cash Flow per Share-3,09 $-3,11 $3,42 $-
Announcement Date02/21/2013
12:15pm
02/20/2014
12:00pm
02/19/2015
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 3 967 M$ -
Entreprise Value (EV) - 3 967 M$
Valuation 2015e 2016e
PER (Price / EPS) 30,6x 24,7x
Capitalization / Revenue 2,81x 2,59x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) 0,85% 0,93%
Price to book (Price / BVPS) - -
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 13,4% 15,0%
operating Leverage (Delta EBIT / Delta Sales) - 2,50x
Net Margin (Net Profit / Revenue) 9,35% 10,7%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 12,8% -
Rate of Dividend 26,1% 22,9%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   - -
Cash Flow / Sales (Taux d'autofinancement) 15,8% 16,1%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend